Senate Report Accuses Company of Manipulating Researchers' Studies
- More Scrutiny on Conflicts of Interest
- WE LOVE OUR STIMULANTS IN THIS COUNTRY
- Quick Takes: Chu and Duncan Share Views, Georgia GOP vs. Stem Cell Studies, When 'or More' Isn't Enough, Part-Time MBA Woes, Israel Programs Dropped, Vatican Praises Shifts in Seminaries, Classes on Good Friday Restored, Grow Your Own Research Subjects
- Scrutiny of Researcher-Industry Ties
- Quick Takes: Failure to Report at Harvard, Another Try at Antioch, 2 Accused of Harassment Quit Southwestern, Yale Expands, Immigration Status Limits Tuition Pledge, Knox Loses Appeal on $1M Verdict, Eastern MIch. to Pay $350K, A President-Elect Dies
A U.S. Senate report Thursday accused the pharmaceutical company Medtronic of heavily editing and even writing sections of journal articles published by academic researchers on its consulting payroll, without those ties or the company's involvement being reported. The Democratic and Republican leaders of the Senate Finance Committee, Montana's Max Baucus and Charles Grassley of Iowa, said their 16-month investigation had found significant evidence of undisclosed ghostwriting of positive articles about the company's product known as InFuse. Medtronic disputed some of the report's findings in a statement, and an article in The Wall Street Journal included rebuttals from some of the academic researchers.